Upadacitinib was associated with AEs such as acne, nasopharyngitis, upper respiratory tract infections, herpes simplex and zoster infections, elevations in creatine phosphokinase (CPK), and headache [16-20]. The gene discussed is PIK3C2A; the disease is nasopharyngitis.